Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Summit Biosciences
Lexington, Kentucky, United Statessummitbiosciences.com ↗
- Ownership
- Private
- Employees
- ~72
- Development stage
- Other
01
Overview
Summit Biosciences specialized in the development, manufacturing, and commercialization of prescription nasal spray products. The company had an extensive track record of innovation in unit dose nasal spray medicines with FDA/EMA-approved facilities. In January 2024, it was acquired by Kindeva Drug Delivery to expand their capabilities in intranasal drug-device combination products. Clinical results for specific programs are not publicly detailed.
- Therapeutic areas
- Neurology
- Modalities
- Nasal spraysIntranasal drug delivery
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Summit Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Summit Biosciences.